{
    "nctId": "NCT04135157",
    "briefTitle": "Pectoral Nerve Block II and Erector Spine Plane Block in Breast Cancer Surgery",
    "officialTitle": "Research of the Effects of Pectoralis Nerve Block II and Erector Spina Plan Block in Breast Cancer Surgery",
    "overallStatus": "COMPLETED",
    "conditions": "Anesthesia, Analgesia, Acute Pain, Chronic Pain, Pectoralis Nerve Block, Erector Spine Plane Block, Patient Controlled Analgesia",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 90,
    "primaryOutcomeMeasure": "Opioid consumption in the first 24 hours after surgery",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* ASA 1-2 patients between the age of 18-65, scheduled for elective unilateral segmental mastectomy + sentinel lymph node biopsy\n\nExclusion Criteria:\n\n* Age \\<18 or\\> 65, ASA 3-4 patients\n* Obesity (\\> 100 kg, BMI\\> 35 kg / m2)\n* Patients undergoing bilateral mastectomy\n* Pregnancy\n* Contraindication of regional anesthesia (coagulopathy, abnormal INR, thrombocytopenia, infection at the injection site)\n* Serious renal, cardiac, hepatic disease\n* Hypersensitivity to local anesthetics or a history of allergy\n* Patients with a history of opioid use longer than four weeks\n* Patients with psychiatric disorders or communication difficulties\n* Patients with chest deformity\n* Patients with previous breast surgery except diagnostic biopsies\n* Patients who do not want to participate",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}